In ovarian cancer cells, leptin maintains stem-like characteristics and drives a more aggressive transcriptional phenotype, explaining the poor prognosis observed in obese patients with leptin resistance or chronic hyperleptinaemia (121, 122). This evidence concerns the gene LEP and ovarian carcinoma.